Sun Pharmaceutical founder and managing director Dilip Shanghvi took a 99 per cent pay cut in his remuneration during 2018-19. Eyebrows were understandably raised about what Shanghvi, the founder of Sun Pharmaceuticals saw in the heavily indebted wind turbine maker as he cut a cheque for Rs.18 billion. Dilip Shanghvi takes 99% pay cut despite Sun Pharma's 27% earnings growth Sun Pharma's Dilip Shanghvi may enter wind energy biz with a stake in Suzlon Dilip Shanghvi, promoter and managing director of Sun Pharmaceutical Industries and is ranked as the second richest Indian, with a net worth of about $18 billion, is reportedly in talks with Tulsi Tantia's Suzlon Energy to acquire a stake in the debt-laden wind turbine maker. Suraksha Realty, a real estate company owned by Sudhir Valia, the brother-in-law of Sun Pharma promoter Dilip Shanghvi, raised money using Sun Pharma shares as collateral at least three times in the last two years, The Economic Times reported citing a document. The promoters of Sun Pharmaceuticals increased their stake in the company marginally during the July-September quarter to 54.55 per cent from 54.38 per cent at the end of June. Shanghvi’s brother-in-law and then-full-time director Sudhir Valia, a protagonist in the brouhaha, also saw his 2018-19 remuneration decrease by 99.7% to merely Rs 79,201. His brother-in-law and co-promoter Sudhir Valia too didn’t take any salary in FY19. Mukesh Ambani, Azim Premji, Dilip Shanghvi among world's 50 wealthiest people . Both his children, Aalok and Vidhi work in Sun Pharmaceuticals. By Qrius. I think our assessment is that FDA has become far more vigilant and is enforcing the existing law much more strictly after some of the issues which exposed US citizens to products that caused loss of life. Law And Policy; Mutual Funds; BQ Learning; Economy & Finance; BloombergQuint. Shares of Sun Pharma being used collateral to raise money for Suraksha has already happened for at least 3 occasions in the last 2 years. And this is also the mandate of the current FDA Commissioner. 100cr. Three Indians - Mukesh Ambani, Azim Premji and Dilip Shanghvi - have made it to a global list of 50 wealthiest people that is topped by Bill Gates. Sun Pharma Managing Director Dilip Shanghvi's mother Kumud S Shanghvi, one of the promoters of Sun Pharma, has gifted nearly 31 lakh shares worth Rs 282 crore to her daughter-in-law Vibha D Shanghvi. Markets; Business; BQ Blue Exclusive; Videos; Coronavirus Pandemic; Dilip Shanghvi, chairman and founder of Sun Pharmaceutical Industries, right, speaks during an interview in Mumbai. Find Dilip Shanghvi news headlines, photos, videos, comments, blog posts and opinion at The Indian Express. Dilip Shanghvi-led Sun Pharma has reportedly helped realty firm Suraksha Realty, owned by the brother-in-law of Sanghvi, raise funds through pledging the drug-making company's shares, said a media report. Dilip Shanghvi: It is very difficult to answer a very generic question. Jan 28, 2016, 12:46 PM IST (Photographer: Kanishka Sonthalia/Bloomberg) China's War on Healthcare Costs Lures India's Biggest Drugmaker . In the late 1970s, a young man called Dilip Shanghvi, son of a Calcutta-based (now Kolkata) wholesale distributor of medicines, decided to set up a drug company. Around early January, SFPL pledged a portion of its stake in Sun Pharma to help Suraksha Realty raise Rs. He chose to forego most of his salary and took home Re 1 as the company optimised operational costs due to pricing pressure. Sun Pharma’s managing director, Dilip Shanghvi, took a huge 99% pay cut for the fiscal year ended March, despite the firm’s sales and net profit gains. Suraksha Realty, owned by Sudhir Valia, raised money using Sun Pharma shares as collateral at least thrice during the past two years. Sun Pharma promoter Shanghvi's brother-in-law Sudhir Valia to pick 26% | Telenor rings in new Indian partner Mr. Dilip Shanghvi, Managing Director - Sun Pharmaceutical Industries Ltd added, "IPA member companies undertook comprehensive efforts in identifying social causes to support and accordingly made relevant interventions. Shanghvi took home Re 1 as salary in FY19 from around Rs 3 crore in FY18. The latest fundraising of Rs 100 crore for Suraksha Realty was through commercial paper and Shanghvi Finance, a major … Dilip Shanghvi is married to Vibha S Shanghvi. Sun Pharma's Dilip Shanghvi takes 99% pay cut. But the list of investors — including the family and associates of the other promoter, Dilip Shanghvi of Sun Pharma — is 165-entry long. However, Dilip Shanghvi is groping for the silver lining to keep the ‘Sun’ from failing. She was gifted Rs. Sanghvi's brother-in-law Sudhir Valia, who stepped down as full-time director of the company and continued as a non-executive director of the pharma company, also drew Re 1 remuneration in the same period. The wealth of Dilip Shantilal Sanghvi, the founder of Sun Pharmaceuticals, plummeted by $14.1 billion in the last 2 years. Ari … A ₹1,085 crore one-time charge following a governance scandal hit profit.Sudhir Valia, brother-in law of founder Dilip Shanghvi, will become a non-executive director from whole-time director Dilip Shanghvi's mother gifts Sun Pharma shares to his wife. It had been barely two months since Dilip Shanghvi Family and Associates (DSA) picked up 23% stake in Suzlon Energy at Rs.18 per share in early 2015. It may be noted that he took a pay cut in the year when the drugmaker clocked a net profit of 27 per cent. 280 crore worth shares by her mother-in-law in 2015, increasing her stake in company from 0.28 percent to 0.43 percent. Dilip Shanghvi, Managing Director, Sun Pharma said, 'We are excited by the robust preclinical data for GL0034 and believe that it has significant potential. Valia is also the brother-in-law of Dilip Shanghvi, which makes him a related party for Sun Pharma. Sun Pharmaceutical Industries Ltd.’s promoter Dilip Shanghvi denied allegations of insider trading and poor corporate governance after a report that the market regulator may reopen its probe against India’s largest drugmaker and some of its promoters for various lapses. The plunge came as Sun’s leadership was recently embroiled in allegations of dubious corporate governance practices. Kumud Shanghvi, the mother of Dilip Shanghvi, the billionaire managing director of Indian pharmaceutical company Sun Pharmaceutical Industries, has given nearly 3.1 million shares worth ₹282 crore (US$45.64 million) to her daughter-in-law Vibha Shanghvi, according to The Financial Express.. Kumud’s total number of shares has come down from 3.28 million to 200,000 following the gift. https://www.worldblaze.in/dilip-sanghvi-net-worth-and-biography The couple has two children- a daughter and a son. As on July 31, the valuation of his shareholding in the company stood at Rs 9,830 crore. Sun Pharma founder Dilip Shanghvi's mother Kumud has gifted nearly 31 lakh shares in the drugmaker to her daughter-in-law Vibha, according to a regulatory filing on the Bombay Stock Exchange. Dilip Shanghvi Latest breaking news, pictures, photos and Video News. By Ayushi Gupta. Vidhi Dilip Shanghvi is Promoter at Sun Pharmaceutical Industries Ltd. View Vidhi Dilip Shanghvi’s professional profile on Relationship Science, the database of decision makers. The note raised questions about inadequate disclosures regarding the role of promoter Dilip Shanghvi’s brother-in-law Sudhir Valia, Sun’s past links with banned traders Ketan Parekh and Dharmesh Doshi, related party transactions involving promoter Shanghvi and guarantees given to real estate firm Suraksha Realty.